LYEL·55083R203·US·equity·Healthcare - Biotechnology-13D/G
LYEL (LYELL IMMUNOPHARMA INC) is held by 43 institutional investors as of Q1 2026. Largest holders: MILLENNIUM MANAGEMENT LLC ($9.2M), CITADEL ADVISORS LLC ($7.7M), SUSQUEHANNA INTERNATIONAL GROUP, LLP ($6.2M). Net institutional sentiment: Bullish.
See how LYEL's score breaks down across 4 SEC sources
Showing 1-20 of 47
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer